Data Integrity Working Group
Failures in data governance and data integrity have plagued the industry for over 15 years. The US FDA, European inspectorate, and WHO have enforced such actions in the US and Europe including countries such as India, China, and Japan. The industry does not appear to have fully met the data integrity requirements and expectations. The Rx-360 Data Integrity Working Group will develop processes, tools, and training to incorporate data integrity best practices.
If you are interested in joining this Working Group please contact us at info@rx-360.org
Watch this Brief Member Testimonial
“I’m one of the chairs of the data integrity work group. And the big benefit again is kind of working with experts in the industry. So from the data integrity perspective, we have a true global subject matter experts participate in this working group work, meet with them on a biweekly basis, become friends with many of them, some of the benefits behind that, in addition to those friendships and gaining that is being able to work with the team to create resources and tools to help not only my company, Eli Lilly and Company, but all of the Rx-360 colleagues globally.”
Jim Henderson, Eli Lilly and Company
Data Integrity Guide: Spreadsheet Validation
Strengthen Spreadsheet Controls. Reduce Compliance Risk. Spreadsheets remain one of the most widely used tools across pharmaceutical operations, supporting everything from laboratory calculations and stability programs to equipment maintenance, quality systems, and product release decisions. […]
Rx-360 Vendor Questionnaire Quality System
